An integrated microfluidic system for screening of peptides specific to colon cancer cells and colon cancer stem cells using the phage display technology

Yu Jui Che, Huei Wen Wu, Lein Yu Hung, Hwan You Chang, Kuan Wang, Gwo Bin Lee

研究成果: 書貢獻/報告類型會議貢獻

1 引文 (Scopus)

摘要

Reagents binding specifically to target molecules are essential tools for clinical diagnosis and targeted therapy. Screening of target cell-surface specific affinity reagents with bench-top methods has some drawbacks, including time-consuming, labor-intensive and requirement of large-scale instrument. Microfluidic platforms may overcome these drawbacks because they could automate and complete the screening process within a shorter period of time. Phage display is a promising technology in selection of cell-surface specific peptides. In recent years, a subpopulation of tumor cells named cancer stem cells is believed to be the tumorigenic cells and closely associated with metastasis. A specific peptide that can recognize and differentiate cancer stem cells from the rest of cancer cell population is therefore useful for early diagnosis and targeted therapy. In this study, selection of M13 phage displayed peptides that bind with colon cancer cells and colon cancer stem cells using an integrated microfluidic system was successfully demonstrated. Compared with the traditional methods, the total selection process was shortened to 36 hours while traditional method needs almost a month. More importantly, the screening process can be automated and performed on a single microfluidic chip. The developed technique may be promising for early diagnosis of cancer and target therapeutics.
原文英語
主出版物標題9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014
發行者Institute of Electrical and Electronics Engineers Inc.
頁面440-443
頁數4
ISBN(電子)9781479947270
DOIs
出版狀態已發佈 - 九月 23 2014
對外發佈Yes
事件9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014 - Waikiki Beach, 美国
持續時間: 四月 13 2014四月 16 2014

出版系列

名字9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014

其他

其他9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014
國家美国
城市Waikiki Beach
期間4/13/144/16/14

ASJC Scopus subject areas

  • Control and Systems Engineering
  • Electrical and Electronic Engineering

引用此文

Che, Y. J., Wu, H. W., Hung, L. Y., Chang, H. Y., Wang, K., & Lee, G. B. (2014). An integrated microfluidic system for screening of peptides specific to colon cancer cells and colon cancer stem cells using the phage display technology. 於 9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014 (頁 440-443). [6908845] (9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014). Institute of Electrical and Electronics Engineers Inc.. https://doi.org/10.1109/NEMS.2014.6908845

An integrated microfluidic system for screening of peptides specific to colon cancer cells and colon cancer stem cells using the phage display technology. / Che, Yu Jui; Wu, Huei Wen; Hung, Lein Yu; Chang, Hwan You; Wang, Kuan; Lee, Gwo Bin.

9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014. Institute of Electrical and Electronics Engineers Inc., 2014. p. 440-443 6908845 (9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014).

研究成果: 書貢獻/報告類型會議貢獻

Che, YJ, Wu, HW, Hung, LY, Chang, HY, Wang, K & Lee, GB 2014, An integrated microfluidic system for screening of peptides specific to colon cancer cells and colon cancer stem cells using the phage display technology. 於 9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014., 6908845, 9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014, Institute of Electrical and Electronics Engineers Inc., 頁 440-443, 9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014, Waikiki Beach, 美国, 4/13/14. https://doi.org/10.1109/NEMS.2014.6908845
Che YJ, Wu HW, Hung LY, Chang HY, Wang K, Lee GB. An integrated microfluidic system for screening of peptides specific to colon cancer cells and colon cancer stem cells using the phage display technology. 於 9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014. Institute of Electrical and Electronics Engineers Inc. 2014. p. 440-443. 6908845. (9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014). https://doi.org/10.1109/NEMS.2014.6908845
Che, Yu Jui ; Wu, Huei Wen ; Hung, Lein Yu ; Chang, Hwan You ; Wang, Kuan ; Lee, Gwo Bin. / An integrated microfluidic system for screening of peptides specific to colon cancer cells and colon cancer stem cells using the phage display technology. 9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014. Institute of Electrical and Electronics Engineers Inc., 2014. 頁 440-443 (9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014).
@inproceedings{583861dead3f4a1ca7a9d5c62f4bfa94,
title = "An integrated microfluidic system for screening of peptides specific to colon cancer cells and colon cancer stem cells using the phage display technology",
abstract = "Reagents binding specifically to target molecules are essential tools for clinical diagnosis and targeted therapy. Screening of target cell-surface specific affinity reagents with bench-top methods has some drawbacks, including time-consuming, labor-intensive and requirement of large-scale instrument. Microfluidic platforms may overcome these drawbacks because they could automate and complete the screening process within a shorter period of time. Phage display is a promising technology in selection of cell-surface specific peptides. In recent years, a subpopulation of tumor cells named cancer stem cells is believed to be the tumorigenic cells and closely associated with metastasis. A specific peptide that can recognize and differentiate cancer stem cells from the rest of cancer cell population is therefore useful for early diagnosis and targeted therapy. In this study, selection of M13 phage displayed peptides that bind with colon cancer cells and colon cancer stem cells using an integrated microfluidic system was successfully demonstrated. Compared with the traditional methods, the total selection process was shortened to 36 hours while traditional method needs almost a month. More importantly, the screening process can be automated and performed on a single microfluidic chip. The developed technique may be promising for early diagnosis of cancer and target therapeutics.",
keywords = "biomarker, cancer stem cell, colon cancer, microfluidics, phage display library, screening",
author = "Che, {Yu Jui} and Wu, {Huei Wen} and Hung, {Lein Yu} and Chang, {Hwan You} and Kuan Wang and Lee, {Gwo Bin}",
year = "2014",
month = "9",
day = "23",
doi = "10.1109/NEMS.2014.6908845",
language = "English",
series = "9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014",
publisher = "Institute of Electrical and Electronics Engineers Inc.",
pages = "440--443",
booktitle = "9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014",
address = "United States",

}

TY - GEN

T1 - An integrated microfluidic system for screening of peptides specific to colon cancer cells and colon cancer stem cells using the phage display technology

AU - Che, Yu Jui

AU - Wu, Huei Wen

AU - Hung, Lein Yu

AU - Chang, Hwan You

AU - Wang, Kuan

AU - Lee, Gwo Bin

PY - 2014/9/23

Y1 - 2014/9/23

N2 - Reagents binding specifically to target molecules are essential tools for clinical diagnosis and targeted therapy. Screening of target cell-surface specific affinity reagents with bench-top methods has some drawbacks, including time-consuming, labor-intensive and requirement of large-scale instrument. Microfluidic platforms may overcome these drawbacks because they could automate and complete the screening process within a shorter period of time. Phage display is a promising technology in selection of cell-surface specific peptides. In recent years, a subpopulation of tumor cells named cancer stem cells is believed to be the tumorigenic cells and closely associated with metastasis. A specific peptide that can recognize and differentiate cancer stem cells from the rest of cancer cell population is therefore useful for early diagnosis and targeted therapy. In this study, selection of M13 phage displayed peptides that bind with colon cancer cells and colon cancer stem cells using an integrated microfluidic system was successfully demonstrated. Compared with the traditional methods, the total selection process was shortened to 36 hours while traditional method needs almost a month. More importantly, the screening process can be automated and performed on a single microfluidic chip. The developed technique may be promising for early diagnosis of cancer and target therapeutics.

AB - Reagents binding specifically to target molecules are essential tools for clinical diagnosis and targeted therapy. Screening of target cell-surface specific affinity reagents with bench-top methods has some drawbacks, including time-consuming, labor-intensive and requirement of large-scale instrument. Microfluidic platforms may overcome these drawbacks because they could automate and complete the screening process within a shorter period of time. Phage display is a promising technology in selection of cell-surface specific peptides. In recent years, a subpopulation of tumor cells named cancer stem cells is believed to be the tumorigenic cells and closely associated with metastasis. A specific peptide that can recognize and differentiate cancer stem cells from the rest of cancer cell population is therefore useful for early diagnosis and targeted therapy. In this study, selection of M13 phage displayed peptides that bind with colon cancer cells and colon cancer stem cells using an integrated microfluidic system was successfully demonstrated. Compared with the traditional methods, the total selection process was shortened to 36 hours while traditional method needs almost a month. More importantly, the screening process can be automated and performed on a single microfluidic chip. The developed technique may be promising for early diagnosis of cancer and target therapeutics.

KW - biomarker

KW - cancer stem cell

KW - colon cancer

KW - microfluidics

KW - phage display library

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=84908637282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908637282&partnerID=8YFLogxK

U2 - 10.1109/NEMS.2014.6908845

DO - 10.1109/NEMS.2014.6908845

M3 - Conference contribution

AN - SCOPUS:84908637282

T3 - 9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014

SP - 440

EP - 443

BT - 9th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE-NEMS 2014

PB - Institute of Electrical and Electronics Engineers Inc.

ER -